Cite
HARVARD Citation
Tan, S. et al. (2023). Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic review. Cancer epidemiology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tan, S. et al. (2023). Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic review. Cancer epidemiology. p. . [Online].